Skip to content

Prospective Clinical Trial for Evaluation of Efficacy of AI Assistant System in Breast Cancer Screening

Prospective Clinical Trial for Evaluation of Efficacy of AI Assistant System in Breast Cancer Screening

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0009007
Enrollment
3057
Registered
2023-11-30
Start date
2023-04-17
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

National Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women aged 40 to 75 (recommended age group for national cancer screening) 2. Applicants who received a breast cancer screening at the National Cancer Center Cancer Prevention and Screening Center (examiners who received a breast cancer screening at the National Cancer Prevention and Screening Center)

Exclusion criteria

Exclusion criteria: 1. Under 40 years old, over 75 years old 2. If mammography is not performed due to a contraindication to mammography (chest trauma, pregnancy, lactation, etc.)

Design outcomes

Primary

MeasureTime frame
recall rate

Secondary

MeasureTime frame
cancer detection rate;Comparison of differences in recall rates according to clinical factors (age, density, BMI, etc.);Comparison of differences in recall rate and breast cancer detection rate according to clinical factors (age, density, BMI, etc.)

Countries

Korea, Republic of

Contacts

Public ContactJo MI Seon

National Cancer Center

73454@ncc.re.kr+82-31-920-2358

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026